13D·WATCH Activist + Insider Intelligence Live feed Blog About Pilot
ISSUER PROFILE · CIK 0001662774

Quince Therapeutics, Inc.QNCX

1 13D/G filings 1 distinct filers 0 insider transactions (365d)

Cross-Reference Snapshot

Activist filings
1
1 SCHEDULE 13G
Distinct filers
1
single filer
Insiders (365d)
0
0 buys · 0 sales
Latest short DTC
1.00
as of 2026-05-29

Institutional Consensus · 2025-12-31

Held by elite portfolio managers
1 holder · $281K
Point72 Asset Mgmt

13D/G Filings Timeline · 1 total

FiledFormFilerStakeSharesIntent
2026-06-10 SCHEDULE 13G INTEGRATED CORE STRATEGIES (US) LLC view →

FINRA Short Interest History

SettlementShort InterestDays to Cover% Δ vs prior
2026-05-29 2,059,788 1.00 +17.2%
2026-05-15 1,758,167 2.29 -1.5%
2026-04-30 1,784,949 1.07 -8.6%
2026-04-15 1,951,816 1.00 -85.9%
2026-03-31 13,826,556 1.00 +24.0%
2026-03-13 11,153,033 1.00 +34.4%
2026-02-27 8,298,192 1.00 -19.7%
2026-02-13 10,338,418 1.00 +451.1%
2026-01-30 1,875,868 1.00 -45.7%
2026-01-15 3,454,280 3.30 +31.9%
2025-12-31 2,617,907 5.23 +26.8%
2025-12-15 2,064,545 1.71 +33.0%

Alert me when any activist files on Quince Therapeutics, Inc.

Free. We email you when criteria match. One-click unsubscribe in every email.

Track every activist who touches this name.

Custom alerts · full feed · daily intelligence · API. $1,500/mo. Pilots welcome.

Request a pilot →